As shown in Fig. 3a, b, and c, deletion of Trim6 in combination with anti-PD-L1 treatment increased the proportions of CD8+ and CD8+ GZMB+ T cells but not those of CD4+ T cells in MTC tumors. This evidence concerns the gene CD8A and medullary thyroid gland carcinoma.